<DOC>
	<DOCNO>NCT00169702</DOCNO>
	<brief_summary>The study prospective , randomize , open-label study .</brief_summary>
	<brief_title>The Effect Weight Management Program During Treatment With Olanzapine</brief_title>
	<detailed_description>The principal objective trial investigate effect comprehensive behavioural treatment program weight gain schizophrenic patient olanzapine treatment , subjective well-being .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) criteria schizophrenia Ages 18 65 Informed consent Weight gain least 1.5 kg first 4 week A sufficient understanding participate adequately weight management program Patients must agree cooperate test examination require protocol . Each patient must understand nature study must sign informed consent document . Serious , unstable somatic illness Illnesses associated weight gain include renal endocrine disease Weight change great 3 kg precede three month Weight gain less 1.5 kg first 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Schizophrenia , weight management programme</keyword>
</DOC>